Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgo Blockchai. Regulatory News (ARB)

  • There is currently no data for ARB

Update on Restructuring Plan Process

31 Oct 2025 17:00

RNS Number : 7675F
Argo Blockchain PLC
31 October 2025
 

Press Release

31 October 2025

Argo Blockchain plc

("Argo" or "the Company")

Update on Restructuring Plan Process

As previously announced by Argo, the Company is undertaking a recapitalisation by way of a restructuring plan under Part 26A of the Companies Act 2006 (the "Restructuring Plan"). 

As announced yesterday, Argo filed with the High Court of Justice in London a claim form relating to the Restructuring Plan.

Today, Argo has filed with the High Court the court bundles to accompany the claim form.

Copies of the court bundles are available to Plan Participants upon request to argo@is.kroll.com or argo@fladgate.com.

The Restructuring Plan will be structured to enable the Company to rely on the exemption provided by Section 3(a)(10) of the U.S. Securities Act of 1933, as amended, and certain other available exemptions under the U.S. Securities Act of 1933 and applicable state securities laws, in each case with respect to securities expected to be issued under the plan.

For further information please contact:

Argo Blockchain

Investor Relations

ir@argoblockchain.com

Information Agent - Kroll Issuer Services

argo@is.kroll.com

 About Argo:

Argo Blockchain plc is a dual-listed (LSE: ARB; NASDAQ: ARBK) blockchain technology company focused on large-scale cryptocurrency mining. With a mining facility in Quebec and offices in the US, Canada, and the UK, Argo's global, sustainable operations are predominantly powered by renewable energy. In 2021, Argo became the first climate positive cryptocurrency mining company, and a signatory to the Crypto Climate Accord. For more information, visit www.argoblockchain.com.

 

 

Forward looking statements

This announcement contains "forward-looking statements," which can be identified by words like "may," "will," "likely," "should," "expect," "anticipate," "future," "plan," "believe," "intend," "goal," "seek," "estimate," "project," "continue" and similar expressions. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company's current beliefs, expectations and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company's control. The information in this announcement about future plans and objectives of the Company are forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause the Company's actual results and financial condition to differ materially from those indicated in the forward-looking statements include, market and other conditions, the principal risks and uncertainties listed in the risk factors set forth in our Annual Report and Financial Statements and Form 20-F for the year ended 31 December 2024.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REPQFLFXEBLEFBV
Date   Source Headline
5th Aug 20227:00 amRNSJuly 2022 Operational Update
7th Jul 20227:00 amRNSJune 2022 Operational Update
30th Jun 20227:00 amRNSTotal Voting Rights
29th Jun 20221:00 pmRNSResult of Annual General Meeting
27th Jun 202211:30 amRNSQ&A following the Annual General Meeting
15th Jun 202211:05 amRNSSecond Price Monitoring Extn
15th Jun 202211:00 amRNSPrice Monitoring Extension
14th Jun 20227:00 amRNSVoting at the Annual General Meeting
9th Jun 20227:00 amRNSAllotment of New Shares
7th Jun 20227:00 amRNSMay 2022 Operational Update
6th Jun 20222:00 pmRNSNotice of Annual General Meeting
31st May 20227:00 amRNSShare Capital and Total Voting Rights
25th May 20227:00 amRNSPDMR Dealings & Option Grants
19th May 20224:40 pmRNSSecond Price Monitoring Extn
19th May 20224:35 pmRNSPrice Monitoring Extension
18th May 20224:35 pmRNSPrice Monitoring Extension
18th May 20227:00 amRNS1st Quarter Results 2022
16th May 20227:00 amRNSNotice - Q1 2022 Results and Investor Presentation
12th May 202211:05 amRNSSecond Price Monitoring Extn
12th May 202211:00 amRNSPrice Monitoring Extension
12th May 20229:05 amRNSSecond Price Monitoring Extn
12th May 20229:00 amRNSPrice Monitoring Extension
12th May 20227:00 amRNSPosting of Annual Report
9th May 20227:00 amRNSApril 2022 Operational Update
5th May 20224:41 pmRNSSecond Price Monitoring Extn
5th May 20224:35 pmRNSPrice Monitoring Extension
5th May 20229:05 amRNSSecond Price Monitoring Extn
5th May 20229:00 amRNSPrice Monitoring Extension
5th May 20227:00 amRNSEnergization & Official Opening of Helios Facility
4th May 20227:00 amRNSAdditional Equipment Financing from NYDIG
28th Apr 20229:06 amRNSSecond Price Monitoring Extn
28th Apr 20229:00 amRNSPrice Monitoring Extension
28th Apr 20227:00 amRNS2021 Full Year Results
25th Apr 20227:00 amRNSNotice of 2021 Full Year Results
8th Apr 20227:00 amRNSMarch 2022 Operational Update
14th Mar 20227:00 amRNSFleet Swap Agreement with Core Scientific
11th Mar 20227:00 amRNSInvestor Conferences
10th Mar 20227:00 amRNSEquipment Financing Agreement with NYDIG
9th Mar 202211:05 amRNSSecond Price Monitoring Extn
9th Mar 202211:00 amRNSPrice Monitoring Extension
7th Mar 20227:00 amRNSFebruary 2022 Operational Update
28th Feb 20224:42 pmRNSSecond Price Monitoring Extn
28th Feb 20224:36 pmRNSPrice Monitoring Extension
24th Feb 20227:00 amRNSBoard Announcement
17th Feb 20224:36 pmRNSPrice Monitoring Extension
7th Feb 20227:00 amRNSJanuary 2022 Operational Update
19th Jan 20227:00 amRNSUpdate on Argo Labs
7th Jan 20225:48 pmRNSDecember 2021 Operational Update - Replacement
7th Jan 20229:00 amRNSPrice Monitoring Extension
7th Jan 20227:00 amRNSDecember Operational Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.